ArticleJournal of medicinal chemistry2015

Discovery of type II inhibitors of TGFβ-activated kinase 1 (TAK1) and mitogen-activated protein kinase kinase kinase kinase 2 (MAP4K2).

Li Tan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.